Relationship between inflammation biomarkers, antioxidant vitamins, and bone mineral density in patients with metabolic syndrome

Abstract

Few studies have shown the correlation between metabolic syndrome and bone mineral density (BMD). The main pathogenic mechanisms of metabolic syndrome rely on chronic low-level inflammatory status and oxidative stress. There are few studies that examine the gender-specific effects of inflammation and antioxidants on BMD. In this study, we evaluated the relative contribution of these factors in patients with metabolic syndrome. We conducted a cross-sectional study of 67 men and 46 postmenopausal women with metabolic syndrome; metabolic syndrome was defined as having three or more metabolic syndrome risk factors. BMD, body fat mass, and lean body mass were evaluated. We also examined the levels of high sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), adiponectin, vitamin E, and C in serum. Log-transformed hs-CRP levels were significantly higher in lumbar spine osteoporotic subjects than in normal subjects for women but not for men. There was no significant difference between the normal group and the osteoporotic group in other inflammatory markers. Stepwise regression analyses for BMD of the lumbar spine showed that lean body mass and vitamin E were significant determinants in men. Lean body mass and log-transformed hs-CRP were significant determinants in women Analysis for BMD of the femoral neck showed that lean body mass was a significant determinant for both men and women. There was no significant factor among the inflammatory markers or antioxidant vitamins affecting the femoral neck BMD for either gender. In conclusion, while hs-CRP is an independent predictor of the BMD of the lumbar spine in women, vitamin E showed profound effects on BMD in men but not women with metabolic syndrome.

Reductive Stress in Inflammation-Associated Diseases and the Pro-Oxidant Effect of Antioxidant Agents

“…β-Carotene is a chemical compound of the family of terpenes; β-carotene is the most abundant carotenoid in nature, and it is the most important pro-vitamin in the human diet [ 154 ]. The mucosa of the small intestine transforms it into vitamin A, and it is then stored in the liver as a retinol ester [ 155 ].…”

Review article: vitamin D and inflammatory bowel disease – established concepts and future directions

“…Other risk factors include older age, postmenopausal status, smoking, low body mass index, reduced physical activity, malnutrition and low vitamin D status . A chronic inflammatory state, with effects on osteoblast and osteoclast function mediated by cytokines such as TNF‐α, IL‐6 and IL‐1β, likely contributes to bone loss . The risk of low‐trauma fractures in patients with CD is estimated to be increased by about 30%, and in UC about 20%, compared with controls .…”

Revisiting the timing hypothesis: Biomarkers that define the therapeutic window of estrogen for stroke

“…In patients with concomitant metabolic syndrome and reduced bone mineral density or osteoporosis, markers of inflammatory disease and stroke severity such as C-Reactive Protein (CRP) and high sensitive CRP, were significantly higher in postmenopausal women as compared with premenopausal women (Jeon et al 2011), but not with age-matched men (Lee et al 2011). Clinical trials have shown that Vitamin D reduces inflammatory cytokines and levels of CRP (Zittermann, 2003), while Vitamin D deficiency is associated with metabolic syndrome in morbid obesity (Botella-Carretero et al 2007).…”